Evidence map›Paper›PMID 28253315›Full record

SynthesisPloS one2017

Introducing malaria rapid diagnostic tests in private medicine retail outlets: A systematic literature review.

Theodoor Visser, Katia Bruxvoort, Kathleen Maloney, Toby Leslie, Lawrence M Barat, Richard Allan, Evelyn K Ansah, Jennifer Anyanti, Ian Boulton, Siân E Clarke and 22 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 4 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 4 syntheses or guidelines pooled it, 112 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 13 institutions in 8 countries.

Theodoor VisserClinton Health Access Initiative, Boston, Massachusetts, United States of America.
Katia BruxvoortDepartment of Global Health and Development, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Kathleen MaloneyBill and Melinda Gates Foundation, Seattle, Washington, United States of America.
Toby LeslieDepartment of Global Health and Development, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Lawrence M BaratUS President's Malaria Initiative, United States Agency for International Development, Washington DC, United States of America.
Richard AllanMentor Initiative, West Sussex, United Kingdom.
Evelyn K AnsahResearch & Development Division, Ghana Health Service, Accra, Ghana.
Jennifer AnyantiSociety for Family Health, Abuja, Nigeria.
Ian BoultonTropMed Pharma Consulting, Lower Shiplake, Oxfordshire, United Kingdom.
Siân E ClarkeDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Jessica L CohenHarvard T.H. Chan School of Public Health, Boston, United States of America.
Justin M CohenClinton Health Access Initiative, Boston, Massachusetts, United States of America.
Andrea CutherellPopulation Services International, Nairobi, Kenya.
Caitlin DolkartClinton Health Access Initiative, Boston, Massachusetts, United States of America.
Katie EvesMentor Initiative, West Sussex, United Kingdom.
Günther FinkHarvard T.H. Chan School of Public Health, Boston, United States of America.
Catherine GoodmanDepartment of Global Health and Development, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Eleanor HutchinsonDepartment of Global Health and Development, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Sham LalDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Anthony MbonyeMinistry of Health, Kampala, Uganda.
Obinna OnwujekweUniversity of Enugu, Agbani, Enugu State, Nigeria.
Nora PettyClinton Health Access Initiative, Boston, Massachusetts, United States of America.
Julie PontarolloMentor Initiative, West Sussex, United Kingdom.
Stephen PoyerPopulation Services International, Nairobi, Kenya.
David SchellenbergDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Elizabeth StreatMalaria Consortium, London, United Kingdom.
Abigail WardClinton Health Access Initiative, Boston, Massachusetts, United States of America.
Virginia WisemanDepartment of Global Health and Development, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Christopher J M WhittyDepartment of Clinical Research, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Shunmay YeungDepartment of Global Health and Development, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Jane CunninghamGlobal Malaria Program, World Health Organization, Geneva, Switzerland.
Clare I R ChandlerDepartment of Global Health and Development, London School of Hygiene & Tropical Medicine, London, United Kingdom.
London School of Hygiene & Tropical Medicine · GBClinton Health Access Initiative · USHarvard University · USMentor · GBKenya Forest Service · KEBill & Melinda Gates Foundation · USEnugu State University of Science and Technology · NGGhana Health Service · GHMalaria Consortium · GBMinistry of Health · UGSociety for Family Health Nigeria · NGU.S. President's Malaria Initiative · USWorld Health Organization · CH

Funding

Medical Research Council MR/N003810/1World Health Organization 001
6 · The paper itself

Abstract

backgroundMany patients with malaria-like symptoms seek treatment in private medicine retail outlets (PMR) that distribute malaria medicines but do not traditionally provide diagnostic services, potentially leading to overtreatment with antimalarial drugs. To achieve universal access to prompt parasite-based diagnosis, many malaria-endemic countries are considering scaling up malaria rapid diagnostic tests (RDTs) in these outlets, an intervention that may require legislative changes and major investments in supporting programs and infrastructures. This review identifies studies that introduced malaria RDTs in PMRs and examines study outcomes and success factors to inform scale up decisions.

methodsPublished and unpublished studies that introduced malaria RDTs in PMRs were systematically identified and reviewed. Literature published before November 2016 was searched in six electronic databases, and unpublished studies were identified through personal contacts and stakeholder meetings. Outcomes were extracted from publications or provided by principal investigators.

resultsSix published and six unpublished studies were found. Most studies took place in sub-Saharan Africa and were small-scale pilots of RDT introduction in drug shops or pharmacies. None of the studies assessed large-scale implementation in PMRs. RDT uptake varied widely from 8%-100%. Provision of artemisinin-based combination therapy (ACT) for patients testing positive ranged from 30%-99%, and was more than 85% in five studies. Of those testing negative, provision of antimalarials varied from 2%-83% and was less than 20% in eight studies. Longer provider training, lower RDT retail prices and frequent supervision appeared to have a positive effect on RDT uptake and provider adherence to test results. Performance of RDTs by PMR vendors was generally good, but disposal of medical waste and referral of patients to public facilities were common challenges.

conclusionsExpanding services of PMRs to include malaria diagnostic services may hold great promise to improve malaria case management and curb overtreatment with antimalarials. However, doing so will require careful planning, investment and additional research to develop and sustain effective training, supervision, waste-management, referral and surveillance programs beyond the public sector.

Indexed as

Private SectorReagent Kits, DiagnosticHumansMalariaReagent Kits, Diagnostic

Identifiers

PMID28253315
PMCPMC5333947
OpenAlexW2593102090

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.